Autumn Lake Healthcare At Homewood | |
6000 Bellona Avenue, Baltimore, Maryland 21212 | |
(410) 323-4223 | |
Name | Autumn Lake Healthcare At Homewood |
---|---|
Location | 6000 Bellona Avenue, Baltimore, Maryland |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 112 |
Occupancy Rate | 65.63% |
Medicare ID (CCN) | 215074 |
Legal Business Name | Legal Business Name Not Available |
Ownership Type | For Profit - Corporation |
NPI Number | 1033150974 |
Organization Name | MERIDIAN EDGEWOOD LP |
Doing Business As | HOMEWOOD CENTER |
Address | 6000 Bellona Ave, Baltimore, MD 21212 |
Phone Number | 410-323-4223 |
News Archive
NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
CVS Caremark's Pharmacy Benefit Management Customer Care team was awarded a gold medal for Best Customer Service (America's region) and a silver medal for Best Community Spirit by ContactCenterWorld.com at the organization's Top Ranking Performers Awards Conference in Orlando. The awards recognize the best in the contact center industry.
A faculty member in Penn State's College of Agricultural Sciences has received a $7.3 million grant for innovative research on a cellular protein that could be a target for enhancing immune function in response to a variety of diseases and environmental toxins.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
› Verified 5 days ago
NPI Number | 1598947061 |
Organization Name | 6000 BELLONA AVENUE OPERATIONS LLC |
Doing Business As | HOMEWOOD CENTER |
Address | 6000 Bellona Ave, Baltimore, MD 21212 |
Phone Number | 410-323-4223 |
News Archive
NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
CVS Caremark's Pharmacy Benefit Management Customer Care team was awarded a gold medal for Best Customer Service (America's region) and a silver medal for Best Community Spirit by ContactCenterWorld.com at the organization's Top Ranking Performers Awards Conference in Orlando. The awards recognize the best in the contact center industry.
A faculty member in Penn State's College of Agricultural Sciences has received a $7.3 million grant for innovative research on a cellular protein that could be a target for enhancing immune function in response to a variety of diseases and environmental toxins.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
CVS Caremark's Pharmacy Benefit Management Customer Care team was awarded a gold medal for Best Customer Service (America's region) and a silver medal for Best Community Spirit by ContactCenterWorld.com at the organization's Top Ranking Performers Awards Conference in Orlando. The awards recognize the best in the contact center industry.
A faculty member in Penn State's College of Agricultural Sciences has received a $7.3 million grant for innovative research on a cellular protein that could be a target for enhancing immune function in response to a variety of diseases and environmental toxins.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 24.7 | 14.46 |
Percentage of long-stay residents who lose too much weight | 11.11 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 59.02 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.15 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.94 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.38 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.74 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 16.67 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 69.27 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.88 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 56.28 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.94 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.09 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.38 | 95.98 |
Percentage of short-stay residents who made improvements in function | 70.35 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 71.03 | 82.93 |
News Archive
NI Research, the leading publisher of independent research on the neurotherapeutics industry, has released the May issue of NeuroPerspective, which reviews the status and prospects of therapeutics for Parkinson's.
Researchers found that the death rate among children diagnosed with severe falciparum malaria was almost one-fourth lower when they received the drug artesunate rather than the standard treatment of quinine, according to research which was presented at the American Society for Tropical Medicine and Hygiene (ASTMH) over the weekend and published Monday in the Lancet, HealthDay News/U.S. News and World Report writes.
CVS Caremark's Pharmacy Benefit Management Customer Care team was awarded a gold medal for Best Customer Service (America's region) and a silver medal for Best Community Spirit by ContactCenterWorld.com at the organization's Top Ranking Performers Awards Conference in Orlando. The awards recognize the best in the contact center industry.
A faculty member in Penn State's College of Agricultural Sciences has received a $7.3 million grant for innovative research on a cellular protein that could be a target for enhancing immune function in response to a variety of diseases and environmental toxins.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
› Verified 5 days ago
King David Nursing And Rehabilitation Center Location: 4204 Old Milford Mill Road, Baltimore, Maryland 21208 Phone: (410) 486-1500 | |
Autumn Lake Healthcare At Long Green Location: 115 East Melrose Avenue, Baltimore, Maryland 21212 Phone: (410) 435-9073 | |
Levindale Hebrew Ger Ctr & Hsp Location: 2434 W. Belvedere Avenue, Baltimore, Maryland 21215 Phone: (410) 466-8700 | |
Keswick Multi-care Center Location: 700 West 40th Street, Baltimore, Maryland 21211 Phone: (410) 235-8860 | |
St. Elizabeth Rehab. & Nsg. Ce Location: 3320 Benson Avenue, Baltimore, Maryland 21227 Phone: (667) 600-2600 | |
Autumn Lake Healthcare At Homewood Location: 6000 Bellona Avenue, Baltimore, Maryland 21212 Phone: (410) 323-4223 |